Methods of using oxidized fungal antigens in antibody testing

• US 6,867,004 B2
• Filed: 12/21/2001
• Issued: 03/15/2005
• Est. Priority Date: 12/21/2001
• Status: Active Grant

• Current Assignee: Focus Technology Company Limited
• Original Assignee: Focus Technology Company Limited
• Inventors: Arakelov, Sergei, Devor, Ken, Kong, Lilly, Hogrefe, Wayne, Su, Xin, Prince, Harry
• Primary Examiner(s): NAVARRO, ALBERT MARK
• Application Number:
  US10/028,181
• Publication Number:
  US 20030124630A1
• Time in Patent Office: 1,180 Days
• Field of Search: 435/7.1, 435/7.2, 435/7.31, 435/7.92, 435/7.93, 435/7.94, 435/7.95
• US Class Current: 435/7.1
• CPC Class Codes: B82Y 10/00 Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• CPC Class Codes: C07K 14/37 from fungi
• CPC Class Codes: G01N 2469/10 Detection of antigens from microorganism in sample from host
• CPC Class Codes: G01N 2469/20 Detection of antibodies in sample from host which are directed against antigens from microorganisms
• CPC Class Codes: G01N 33/56961 Plant cells or fungi

Abstract

The present invention relates to oxidized fungal antigens and methods of making and using thereof. More particularly, the present invention provides a method for producing an oxidized fungal antigen in culture filtrate. The present invention also provides for the produced oxidized fungal antigens. Devices comprising such oxidized fungal antigens, methods for testing for fungal antibodies using the oxidized fungal antigens and methods for producing anti-fungal antibodies using oxidized fungal antigens are further provided. Antigen detection devices comprising anti-fungal antibodies raised against oxidized fungal antigens produced by the present methods are further provided.

Claims

1. A method of testing an antibody to a fungus in a sample, the method comprising:

a) producing a fungal antigen suitable for testing an antibody to a fungus, comprising providing a fungal antigen as a culture filtrate, the fungal antigen having not been purified by ion exchange chromatography or isoelectric focusing from the culture filtrate, and contacting the fungal antigen with an oxidizing agent to produce an oxidized fungal antigen suitable for testing an antibody to the fungus;

b) contacting a sample suspected of containing an antibody to a fungus with the oxidized fungal antigen produced in step a) under suitable conditions to allow binding of the antibody, if present in the sample, to the oxidized fungal antigen; and

c) assessing binding between the antibody and the oxidized fungal antigen to determine the presence and/or amount of the antibody in the sample.

2. The method of claim 1, wherein the fungus is a pathogenic fungus.

3. The method of claim 1, wherein the sample is a clinical sample.

4. The method of claim 3, wherein the clinical sample is a human clinical sample.

5. The method of claim 1, wherein the fungal antigen has not been purified from the culture filtrate.

6. The method of claim 1, wherein the oxidizing agent is periodate.

7. The method of claim 1, further comprising a step of attaching the oxidized fungal antigen to a surface of a device suitable for testing an antibody to a fungus before contacting the antigen with the sample.

8. The method of claim 1, wherein the binding between the antibody and the oxidized fungal antigen is assessed by a sandwich or competitive assay format.

9. The method of claim 1, wherein the binding between the antibody and the oxidized fungal antigen is assessed by a format selected from the group consisting of an enzyme-linked immunosorbent assay (ELISA), immunoblotting, immunoprecipitation, radioimmunoassay (RIA), immunostaining, latex agglutination, indirect hemagglutination assay (IHA), complement fixation, indirect immunofluorescent assay (IFA), nephelometry, flow cytometry assay, chemiluminescence assay, lateral flow immunoassay, u-capture assay, inhibition assay and avidity assay.

10. The method of claim 1, wherein the binding between the antibody and the oxidized fungal antigen is assessed by an ELISA format.